Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients

Human Immunology

Volumn 71, Issue 12, 2010, Pages 1180-1186

  Yang, Zhi Qing ^a   Yang, Zhan Yu ^a   Zhang, Lei Da ^a   Ping Bie, ^a   Wang, Shu Guang ^a   Ma, Kuan Sheng ^a   Li, Xiao Wu ^a   Dong, Jia Hong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD8+ T cells; FoxP3; Hepatocellular carcinoma; Regulatory T cells

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; TRANSCRIPTION FACTOR FOXP3;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LIVER; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM STAGING; T-LYMPHOCYTES, REGULATORY;

EID: 78149414079     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.09.011     Document Type: Article

References (38)

1. Gralow J., Ozols R.F., Bajorin D.F., Cheson B.D., Sandler H.M., Winer E.P., et al. Clinical cancer advances 2007: Major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology. J Clin Oncol 2008, 26:313-325.
2. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917.
3. Wada Y., Nakashima O., Kutami R., Yamamoto O., Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. J Hepatol 1998, 27:407-414.
4. Chew V., Tow C., Teo M., Wong H.L., Chan J., Gehring A., et al. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. J Hepatol 2010, 52:370-379.
5. Ormandy L.A., Hillemann T., Wedemeyer H., Manns M.P., Greten T.F., Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005, 65:2457-2464.
6. Kobayashi N., Hiraoka N., Yamagami W., Ojima H., Kanai Y., Kosuge T., et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007, 13:902-911.
7. Unitt E., Rushbrook S.M., Marshall A., Davies S., Gibbs P., Morris L.S., et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T-regulatory cells. Hepatology 2005, 41:722-730.
8. Gao Q., Qiu S.J., Fan J., Zhou J., Wang X.Y., Xiao Y.S., et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007, 25:2586-2593.
9. Yang X.H., Yamagiwa S., Ichida T., Matsuda Y., Sugahara S., Watanabe H., et al. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol 2006, 45:254-262.
10. Zhou J., Ding T., Pan W., Zhu L.Y., Li L., Zheng L. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Int J Cancer 2009, 125:1640-1648.
11. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132:2328-2339.
12. Coe D., Begom S., Addey C., White M., Dyson J., Chai J.G. Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy. Cancer Immunol Immunother 2010, 59:1367-1377.
13. Akins E.J., Moore M.L., Tang S., Willingham M.C., Tooze J.A., Dubey P. In situ vaccination combined with androgen ablation and regulatory T-cell depletion reduces castration-resistant tumor burden in prostate-specific pten knockout mice. Cancer Res 2010, 70:3473-3482. 1.
14. Gilliet M., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002, 195:695-704.
15. Najafian N., Chitnis T., Salama A.D., Zhu B., Benou C., Yuan X., et al. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest 2003, 112:1037-1048.
16. Manavalan J.S., Kim-Schulze S., Scotto L., Naiyer A.J., Vlad G., Colombo P.C., et al. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 2004, 16:1055-1068.
17. Shi Z., Okuno Y., Rifa'I M., Endharti A.T., Akane K., Isobe K., Suzuki H. Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. Eur J Immunol 2009, 39:2106-2119.
18. Frisullo G., Nociti V., Iorio R., Plantone D., Patanella A.K., Tonali P.A., Batocchi A.P. CD8(+)FoxP3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients. Hum Immunol 2010, 71:437-441.
19. Meloni F., Morosini M., Solari N., Passadore I., Nascimbene C., Novo M., et al. FoxP3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol 2006, 67:1-12.
20. Filaci G., Fenoglio D., Fravega M., Ansaldo G., Borgonovo G., Traverso P., et al. CD8+ CD28- T regulatory lymphocytes inhibiting T-cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol 2007, 179:4323-4334.
21. Wang R.F. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer. Hum Immunol 2008, 69:811-814.
22. Kiniwa Y., Miyahara Y., Wang H.Y., Peng W., Peng G., Wheeler T.M., et al. CD8+ FoxP3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res 2007, 13:6947-6958.
23. Wei S., Kryczek I., Zou L., Daniel B., Cheng P., Mottram P., et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 2005, 65:5020-5026.
24. Jarnicki A.G., Lysaght J., Todryk S., Mills K.H. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 2006, 177:896-904.
25. Chaput N., Louafi S., Bardier A., Charlotte F., Vaillant J.C., Menegaux F., et al. Identification of CD8+CD25+FoxP3+ suppressive T cells in colorectal cancer tissue. Gut 2009, 58:520-529.
26. Andersen M.H., Sorensen R.B., Brimnes M.K., Svane I.M., Becker J.C., thor Straten P. Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients. J Clin Invest 2009, 119:2245-2256.
27. Cosmi L., Liotta F., Lazzeri E., Francalanci M., Angeli R., Mazzinghi B., et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003, 102:4107-4114.
28. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006, 177:739-747.
29. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001, 410:106-111.
30. Romero P., Zippelius A., Kurth I., Pittet M.J., Touvrey C., Iancu E.M., et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 2007, 178:4112-4119.
31. Dunn G.P., Old L.J., Schreiber R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21:137-148.
32. Gehring A.J., Ho Z.Z., Tan A.T., Aung M.O., Lee K.H., Tan K.C., et al. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2009, 137:682-690.
33. Shi F., Shi M., Zeng Z., Qi R.Z., Liu Z.W., Zhang J.Y., et al. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer 2010, [Epub ahead of print].
34. Wu K., Kryczek I., Chen L., Zou W., Welling T.H. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res 2009, 69:8067-8075.
35. Giannelli G., Fransvea E., Marinosci F., Bergamini C., Colucci S., Schiraldi O., Antonaci S. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am J Pathol 2002, 161:183-193.
36. Stoop J.N., Claassen M.A., Woltman A.M., Binda R.S., Kuipers E.J., Janssen H.L., et al. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol 2008, 129:419-427.
37. Claassen M.A., de Knegt R.J., Tilanus H.W., Janssen H.L., Boonstra A. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepatol 2010, 52:315-321.
38. Endharti A.T., Rifa I.M., Shi Z., Fukuoka Y., Nakahara Y., Kawamoto Y., et al. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 2005, 175:7093-7097.